Nicole Heifner

Nicole Heifner joined Accent in September 2017 and serves as Chief Financial Officer. Prior to joining Accent, Nicole drove two successful initial public offerings in biotechnology – first as the Senior Director of Finance at Epizyme, Inc. and most recently as the Senior Vice President and Chief Accounting Officer at Intellia Therapeutics, Inc., where she oversaw all aspects of finance, accounting and treasury. Nicole began her career in the audit practice of Deloitte. Nicole graduated from Boston University with a degree in business administration, with a focus in accounting.